Literature DB >> 23473593

Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.

Ashit Trivedi1, Richard E Lee, Bernd Meibohm.   

Abstract

With the increased emergence of anti-infective resistance in recent years, much focus has recently been drawn to the development of new anti-infectives and the optimization of treatment regimens and combination therapies for established antimicrobials. In this context, the field of pharmacometrics using quantitative numerical modeling and simulation techniques has in recent years emerged as an invaluable tool in the pharmaceutical industry, academia and regulatory agencies to facilitate the integration of preclinical and clinical development data and to provide a scientifically based framework for rational dosage regimen design and treatment optimization. This review highlights the usefulness of pharmacometric analyses in anti-infective drug development and applied pharmacotherapy with select examples.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473593      PMCID: PMC3809903          DOI: 10.1586/ecp.13.6

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  62 in total

1.  Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.

Authors:  G L Drusano; S L Preston; M H Gotfried; L H Danziger; K A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Role of modelling and simulation: a European regulatory perspective.

Authors:  Siv Jönsson; Anja Henningsson; Monica Edholm; Tomas Salmonson
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

3.  Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.

Authors:  Mahesh N Samtani; Robert Flamm; Koné Kaniga; Partha Nandy
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Population pharmacokinetic and pharmacodynamic modeling of norvancomycin.

Authors:  J Zhang; Y Zhang; Y Shi; J Rui; J Yu; G Cao; J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

5.  Modeling the effects of introducing a new antibiotic in a hospital setting: A case study.

Authors:  Michele L Joyner; Cammey C Manning; Brandi N Canter
Journal:  Math Biosci Eng       Date:  2012-07       Impact factor: 2.080

6.  Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

7.  Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.

Authors:  Ayman M Noreddin; Walid F El-Khatib; Jason Aolie; Ahmed H Salem; George G Zhanel
Journal:  Int J Infect Dis       Date:  2008-11-28       Impact factor: 3.623

8.  Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.

Authors:  Thomas P Lodise; Martina Kinzig-Schippers; George L Drusano; Ulrich Loos; Friedrich Vogel; Jürgen Bulitta; Markus Hinder; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

9.  Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children.

Authors:  Fang Li; Partha Nandy; Shuchean Chien; Gary J Noel; Christoffer W Tornoe
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

10.  The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.

Authors:  H Stass; A Dalhoff
Journal:  Infection       Date:  2005-12       Impact factor: 3.553

View more
  7 in total

Review 1.  Translational PK/PD of anti-infective therapeutics.

Authors:  Chetan Rathi; Richard E Lee; Bernd Meibohm
Journal:  Drug Discov Today Technol       Date:  2016-10-28

Review 2.  Multiscale Modeling in the Clinic: Drug Design and Development.

Authors:  Colleen E Clancy; Gary An; William R Cannon; Yaling Liu; Elebeoba E May; Peter Ortoleva; Aleksander S Popel; James P Sluka; Jing Su; Paolo Vicini; Xiaobo Zhou; David M Eckmann
Journal:  Ann Biomed Eng       Date:  2016-02-17       Impact factor: 3.934

3.  Drug-drug interaction discovery and demystification using Semantic Web technologies.

Authors:  Adeeb Noor; Abdullah Assiri; Serkan Ayvaz; Connor Clark; Michel Dumontier
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

4.  Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.

Authors:  Eric Wenzler; David Butler; Xing Tan; Takayuki Katsube; Toshihiro Wajima
Journal:  Clin Pharmacokinet       Date:  2021-11-18       Impact factor: 5.577

Review 5.  Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants.

Authors:  Tamara van Donge; Julia A Bielicki; John van den Anker; Marc Pfister
Journal:  Front Pediatr       Date:  2018-10-29       Impact factor: 3.418

Review 6.  The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review.

Authors:  Mary E Palmer; Lauren J Andrews; Taylor C Abbey; Ashley E Dahlquist; Eric Wenzler
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

7.  Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.

Authors:  Lina Keutzer; Huifang You; Ali Farnoud; Joakim Nyberg; Sebastian G Wicha; Gareth Maher-Edwards; Georgios Vlasakakis; Gita Khalili Moghaddam; Elin M Svensson; Michael P Menden; Ulrika S H Simonsson
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.